wawang anwarudin. (2026). Cost-Effectiveness Analysis of Rifampicin and Bedaquiline Use for Tuberculosis Treatment: A Systematic Review. Journal of Health Economic and Policy Research (JHEPR), 4(1), 95–103. https://doi.org/10.30595/jhepr.v4i1.442